Rentosertib

An AI-designed drug, Rentosertib, appeared to make patients biologically younger across six ageing clocks in a small trial of idiopathic pulmonary fibrosis, according to research published in Nature B…

Insilico Medicine's AI-discovered lung fibrosis drug, Rentosertib, has entered Phase III clinical trials for idiopathic pulmonary fibrosis, marking a rare late-stage test for AI drug discovery. The co…